Pre-clinical activity of PR-104 as monotherapy and in combination with sorafenib in hepatocellular carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pre-clinical activity of PR-104 as monotherapy and in combination with sorafenib in hepatocellular carcinoma

Published:2015-04-03 Issue:4 Volume:16 Page:610-622
ISSN:1538-4047
Container-title:Cancer Biology & Therapy
language:en
Short-container-title:Cancer Biology & Therapy

Author:

Abbattista Maria R,Jamieson Stephen M F,Gu Yongchuan,Nickel Jennifer E,Pullen Susan M,Patterson Adam V,Wilson William R,Guise Christopher P

Publisher

Informa UK Limited

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1080/15384047.2015.1017171

Reference44 articles.

1. The impact of O2 availability on human cancer

2. Hypoxia, DNA repair and genetic instability

3. Hypoxia signalling through mTOR and the unfolded protein response in cancer

4. The tumor microenvironment and metastatic disease

5. Targeting hypoxia in cancer therapy

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. AKR1C3 promotes progression and mediates therapeutic resistance by inducing epithelial-mesenchymal transition and angiogenesis in small cell lung cancer;Translational Oncology;2024-09

2. Hypoxia as a Target for Combination with Transarterial Chemoembolization in Hepatocellular Carcinoma;Pharmaceuticals;2024-08-11

3. Exploring the Molecular Mechanisms of Huaier on Modulating Metabolic Reprogramming of Hepatocellular Carcinoma: A Study based on Network Pharmacology, Molecular Docking and Bioinformatics;Current Pharmaceutical Design;2024-07

4. Targeting Hypoxia-Inducible Factor-1α for the Management of Hepatocellular Carcinoma;Cancers;2023-05-12

5. The In-Vitro Antitumor Effects of AST-3424 Monotherapy and Combination Therapy With Oxaliplatin or 5-Fluorouracil in Primary Liver Cancer;Frontiers in Oncology;2022-07-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3